Our latest blog post on Alpha Fold 3 explores how AF3 small-molecule docking compares to existing techniques and shows that the story is more nuanced than headlines suggest. inductive.bio/blog/strong-ba…

Thrilled to announce that our work with Nested Therapeutics in drug optimization is now published! 🧬Our ML models helped overcome critical ADME issues to advance Nested’s program. Full story: inductive.bio/news/publicati… #DrugDiscovery #ML #ADME #Biotech

High value AI application: Predicting properties of new drug candidates. Congrats to the Nested Tx and Inductive Bio teams on this successful collaboration showing how new AI models can predict ADME properties and accelerate small molecule drug discovery.

Tired of the local vs. global property-prediction model debate? Why not both? Our blog dives into this debate and provides evidence that a combined global+local approach performs the best. Learn more: inductive.bio/blog/local-vs-… #DrugDiscovery #ML #ADME #Biotech

Guidelines for best practices when using #ML for #ADME drug optimization from Inductive Bio & Nested Therapeutics including a successful case study! #ACSMedChemLett go.acs.org/ape

Join us at #ACSFall 2024! Our own Josh Haimson will be host "Sifting Reality from Hype - AI & ML in Drug Discovery" on Aug 20 with experts from Eli Lilly, Atavistik Bio, & Sanofi. Looking to meet with our team while at #ACS? inductive.bio/contact-us

LLMs’ impact in generative chemistry has been limited to date. We show that a slight change in how you ask the question, simply by switching the input from SMILES to IUPAC, can reduce invalid molecules by >90%. Learn more: inductive.bio/blog/molecular… #GenerativeChemistry #AI #ML

Switching from SMILES to IUPAC reduces invalid molecules generated by LLMs by >90%. Want to know why? Catch up on our blog now: inductive.bio/blog/molecular… #GenerativeChemistry #DrugDiscovery #AI #ML

The rapid rise of AI in drug discovery brings both new opportunities and new challenges to navigate. We’ll be exploring these topics at two sessions at Adam Spangler Spring 2025 this year. Looking to see a demo of Inductive Bio’s latest at #ACS? inductive.bio/book-a-demo

We’re thrilled to announce that our latest generation of Beacon-1 ADMET models secured first place in the recent Polaris blinded prediction challenge focused on ADMET properties in a real ASAP discovery antiviral program. Read about our lessons learned:

Can AI fix one of drug discovery’s biggest bottlenecks? At Inductive Bio, we think so, by making ADMET optimization faster and smarter. In this new Drug Target Review feature, our CEO Josh Haimson shares how: drugtargetreview.com/article/168391…